NCT01735890View on ClinicalTrials.gov

Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Healthy
Interventions
DRUG

CJ Amlodipine/Valsartan 10/160mg Novartis Exforge 10/160mg

single dose

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY